Plas-Free is a clinical-stage medical device company developing an advanced filtration technology for blood purification with the aim to save lives and reduce healthcare costs.  

Plas-Free’s upcoming products provide a simple yet revolutionary approach to advance critical care that address clear unmet needs: 
1.	ClearPlasma for use during massive internal bleeding modifies human plasma to enhance coagulation and hemostasis, effectively reducing bleeding by 55% in clinical studies. 
2.	AAPC-300 for use in HyperAmmonia in liver malfunctions, removes ammonia from the blood stream, effectively extracting > 80% of the ammonia in clinical studies. 

Plas-Free operates as part of a portfolio company of NGT3VC Healthcare venture capital fund. The company is active both in Israel and the US (PA).

To learn more, visit www.plas-free.com or follow us on Linkedin.

Plas-Free

Org chart

Teams

Offices